Tolerance and morphine-induced cross-tolerance are not shown to Tyr-W-MIF-1 analgesia

R L Bell1, A L Vaccarino, R D Olson

  • 1Department of Psychology, University of New Orleans, LA 70148, USA. ribell@iupui.edu

Peptides
|September 30, 1999
PubMed

Insights

This study investigated tolerance and cross-tolerance between Tyr-W-MIF-1 (a mixed agonist/antagonist) and morphine in rats. Results indicate distinct tolerance patterns, with Tyr-W-MIF-1 showing cross-tolerance to morphine but not vice versa.

Area of Science:

  • Pharmacology
  • Neuroscience
  • Drug Dependence Research

Background:

  • Opioid analgesics like morphine are widely used but can lead to tolerance and dependence.
  • Tyr-W-MIF-1 is a novel peptide with mixed agonist/antagonist properties at opioid receptors.
  • Understanding cross-tolerance is crucial for developing safer and more effective pain management strategies.

Purpose of the Study:

  • To investigate the development of tolerance and cross-tolerance between Tyr-W-MIF-1 and morphine.
  • To examine opiate dependence induced by these compounds.
  • To compare the distinct pharmacological profiles of Tyr-W-MIF-1 and morphine regarding tolerance.

Main Methods:

  • Rats were pretreated with Tyr-W-MIF-1, morphine, or saline for four consecutive days.
  • On the fifth day, animals were tested for analgesia induced by Tyr-W-MIF-1 or morphine.
  • Naloxone-precipitated withdrawal was assessed to evaluate opiate dependence.

Main Results:

  • Both Tyr-W-MIF-1 and morphine pretreatment resulted in similar levels of opiate dependence.
  • Animals pretreated with Tyr-W-MIF-1 showed cross-tolerance to morphine analgesia but not tolerance to Tyr-W-MIF-1 itself.
  • Morphine-pretreated animals developed tolerance to morphine but did not exhibit cross-tolerance to Tyr-W-MIF-1 analgesia.

Conclusions:

  • Tolerance and morphine-induced cross-tolerance were not observed for Tyr-W-MIF-1 analgesia.
  • Tyr-W-MIF-1 exhibits a unique tolerance profile compared to morphine.
  • These findings suggest differential mechanisms underlying tolerance to Tyr-W-MIF-1 and morphine.

Related Concept Videos

Combined Effects of Drugs: Antagonism01:30

Combined Effects of Drugs: Antagonism

The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
Desensitization and Tachyphylaxis01:20

Desensitization and Tachyphylaxis

Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
Several...
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2, D-Pen5]-enkephalin or DPDPE for...
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...